Dosing strategies for switching from oral risperidone to paliperidone palmitate: Effects on clinical outcomes

INTRODUCTION: There are currently no guidelines for switching patients from oral risperidone to paliperidone palmitate (Invega Sustenna®). Furthermore, the paliperidone long-acting injectable (LAI) package insert does not recommend bridging with oral antipsychotics, which may result in inadequate se...

Full description

Saved in:
Bibliographic Details
Published in:Ment Health Clin
Main Authors: Hsia, Stephanie L., Leckband, Susan G., Rao, Sanjai, Jackson, Elizabeth, Lacro, Jonathan P.
Format: Artigo
Language:Inglês
Published: College of Psychiatric & Neurologic Pharmacists 2018
Subjects:
Innovative Practices
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007563/
https://ncbi.nlm.nih.gov/pubmed/29955505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.05.095
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items